Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor

The epidermal growth factor receptor (EGFR) is frequently dysregulated in human malignancies and a validated target for cancer therapy. Two monoclonal anti-EGFR antibodies (cetuximab and panitumumab) are approved for clinical use. However, the percentage of patients responding to treatment is low an...

Full description

Saved in:
Bibliographic Details
Main Authors: Koefoed, Klaus, Steinaa, Lucilla, Søderberg, Josefine Nielsen, Kjær, Ida, Jacobsen, Helle Jane, Meijer, Per-Johan, Haurum, John Sørensen, Jensen, Allan, Kragh, Michael, Andersen, Peter Sejer, Pedersen, Mikkel Wandahl
Format: Artigo
Language:Inglês
Published: Landes Bioscience 2011
Subjects:
Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3242845/
https://ncbi.nlm.nih.gov/pubmed/22123060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.6.17955
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items